Trial · NCT02879747
Adverse events21
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | virosis | Infections and infestations | Decreased GH Dose | 20 | 27 | 52 |
| other | virosis | Infections and infestations | Unchanged GH Dose | 25 | 38 | 46 |
| other | virosis | Infections and infestations | Control Group | 24 | 33 | 53 |
| serious | Otitis media | Ear and labyrinth disorders | Decreased GH Dose | 1 | 27 | 1 |
| serious | Otitis media | Ear and labyrinth disorders | Unchanged GH Dose | 0 | 38 | 0 |
| serious | Otitis media | Ear and labyrinth disorders | Control Group | 0 | 33 | 0 |
| serious | Abdominal pain | Gastrointestinal disorders | Decreased GH Dose | 1 | 27 | 1 |
| serious | Abdominal pain | Gastrointestinal disorders | Unchanged GH Dose | 1 | 38 | 1 |
| serious | Abdominal pain | Gastrointestinal disorders | Control Group | 0 | 33 | 0 |
| serious | facial nerve palsy due to tick disease | Infections and infestations | Decreased GH Dose | 1 | 27 | 1 |
| serious | facial nerve palsy due to tick disease | Infections and infestations | Unchanged GH Dose | 0 | 38 | 0 |
| serious | facial nerve palsy due to tick disease | Infections and infestations | Control Group | 0 | 33 | 0 |
| serious | accident | Injury, poisoning and procedural complications | Decreased GH Dose | 0 | 27 | 0 |
| serious | accident | Injury, poisoning and procedural complications | Unchanged GH Dose | 1 | 38 | 1 |
| serious | accident | Injury, poisoning and procedural complications | Control Group | 0 | 33 | 0 |
| serious | fracture | Injury, poisoning and procedural complications | Decreased GH Dose | 0 | 27 | 0 |
| serious | fracture | Injury, poisoning and procedural complications | Unchanged GH Dose | 2 | 38 | 2 |
| serious | fracture | Injury, poisoning and procedural complications | Control Group | 1 | 33 | 1 |
| serious | Urinary tract infection (upper) | Infections and infestations | Decreased GH Dose | 0 | 27 | 0 |
| serious | Urinary tract infection (upper) | Infections and infestations | Unchanged GH Dose | 0 | 38 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02879747/events